{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.2","meta":{"versionId":"3","lastUpdated":"2015-05-23T01:00:02.000-04:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>Rituximab Administration</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <a href=\"http://www.snomed.org/\">\n            <code>http://snomed.info/sct</code>\n          </a>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=108809004\">108809004</a>\n              </td>\n              <td>Rituximab (product)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=327393005\">327393005</a>\n              </td>\n              <td>Rituximab 10mg/mL injection concentrate 10mL vial (product)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=327394004\">327394004</a>\n              </td>\n              <td>Rituximab 10mg/mL infusion concentrate 50mL vial (product)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=386919002\">386919002</a>\n              </td>\n              <td>Rituximab (substance)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=442108004\">442108004</a>\n              </td>\n              <td>Adverse reaction to rituximab administered by infusion (disorder)</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.2","version":"20150523","name":"Rituximab Administration","status":"active","date":"2015-05-23T01:00:02-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://snomed.info/sct","concept":[{"code":"108809004","display":"Rituximab (product)"},{"code":"327393005","display":"Rituximab 10mg/mL injection concentrate 10mL vial (product)"},{"code":"327394004","display":"Rituximab 10mg/mL infusion concentrate 50mL vial (product)"},{"code":"386919002","display":"Rituximab (substance)"},{"code":"442108004","display":"Adverse reaction to rituximab administered by infusion (disorder)"}]}]}}